OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fingolimod Modulates Dendritic Architecture in a BDNF-Dependent Manner
Abhisarika Patnaik, Eleonora Spiombi, Angelisa Frasca, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 9, pp. 3079-3079
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

CDKL5 deficiency disorder: clinical features, diagnosis, and management
Helen Leonard, Jenny Downs, Tim A. Benke, et al.
The Lancet Neurology (2022) Vol. 21, Iss. 6, pp. 563-576
Open Access | Times Cited: 88

Brain-Derived Neurotrophic Factor (BDNF) in Huntington’s Disease: Neurobiology and Therapeutic Potential
Khairunnuur Fairuz Azman, Rahimah Zakaria
Current Neuropharmacology (2025) Vol. 23, Iss. 4, pp. 384-403
Closed Access | Times Cited: 1

Microglia and BDNF at the crossroads of stressor related disorders: Towards a unique trophic phenotype
Natalie Prowse, Shawn Hayley
Neuroscience & Biobehavioral Reviews (2021) Vol. 131, pp. 135-163
Open Access | Times Cited: 48

Molecular Pharmacology and Novel Potential Therapeutic Applications of Fingolimod
Safura Pournajaf, Leila Dargahi, Mohammad Javan, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 33

Diverse Functions of Multiple Bdnf Transcripts Driven by Distinct Bdnf Promoters
He You, Bai Lu
Biomolecules (2023) Vol. 13, Iss. 4, pp. 655-655
Open Access | Times Cited: 20

Abnormal oligodendrocyte function in schizophrenia explains the long latent interval in some patients
Jeffrey Fessel
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 19

Neural precursor cells rescue symptoms of Rett syndrome by activation of the Interferon γ pathway
Angelisa Frasca, Federica Miramondi, Erica Butti, et al.
EMBO Molecular Medicine (2024) Vol. 16, Iss. 12, pp. 3218-3246
Open Access | Times Cited: 4

Therapeutic effects of CGS21680, a selective A2A receptor agonist, via BDNF-related pathways in R106W mutation Rett syndrome model
Youngin Jeong, Min Woo Kim, Seulgi Lee, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 183, pp. 117821-117821
Closed Access

The protective effect of Fingolimod upon visual behavior in a demyelination animal model is associated with synaptopathy prevention
Ana C. Pereira, Susana De La Cruz, Luiza dos Santos Heringer, et al.
NeuroToxicology (2025)
Closed Access

Reversing Alzheimer's disease dementia with clemastine, fingolimod, or rolipram, plus anti‐amyloid therapy
Jeffrey Fessel
Alzheimer s & Dementia Translational Research & Clinical Interventions (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 16

Cure of Alzheimer’s Dementia Requires Addressing All of the Affected Brain Cell Types
Jeffrey Fessel
Journal of Clinical Medicine (2023) Vol. 12, Iss. 5, pp. 2049-2049
Open Access | Times Cited: 10

Hotair and Malat1 Long Noncoding RNAs Regulate Bdnf Expression and Oligodendrocyte Precursor Cell Differentiation
Fatemeh Khani-Habibabadi, Leila Zare, Mohammad Ali Sahraian, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 7, pp. 4209-4222
Open Access | Times Cited: 14

Mass Generation, Neuron Labeling, and 3D Imaging of Minibrains
Subashika Govindan, Laura Batti, Samira F. Osterop, et al.
Frontiers in Bioengineering and Biotechnology (2021) Vol. 8
Open Access | Times Cited: 20

The Compelling Role of Brain‐Derived Neurotrophic Factor Signaling in Multiple Sclerosis: Role of BDNF Activators
Hayder M. Al‐kuraishy, Ghassan M. Sulaiman, Hamdoon A. Mohammed, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 12
Open Access | Times Cited: 2

Pharmacological Strategies to Improve Dendritic Spines in Alzheimer’s Disease
Miren Ettcheto, Oriol Busquets, Amanda Cano, et al.
Journal of Alzheimer s Disease (2020) Vol. 82, Iss. s1, pp. S91-S107
Open Access | Times Cited: 19

Serum and cerebrospinal fluid BDNF concentrations are associated with neurological and cognitive improvement in multiple sclerosis: A pilot study
Yavor Yalachkov, Victoria Anschütz, Michelle Maiworm, et al.
Multiple Sclerosis and Related Disorders (2023) Vol. 71, pp. 104567-104567
Closed Access | Times Cited: 6

Immune System and Brain/Intestinal Barrier Functions in Psychiatric Diseases: Is Sphingosine-1-Phosphate at the Helm?
David Martín‐Hernández, Marina Muñoz‐López, Hiram Tendilla‐Beltrán, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12634-12634
Open Access | Times Cited: 5

Neural precursor cells rescue symptoms of Rett syndrome by activation of the Interferon γ pathway
Angelisa Frasca, Federica Miramondi, Erica Butti, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Siponimod treatment response shows partial BDNF dependency in multiple sclerosis models
Hasan Hüseyin Hendek, Alina Blusch, Neele Heitmann, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access

Molecular Mechanisms of Synaptic Plasticity 2.0: Dynamic Changes in Neurons Functions, Physiological and Pathological Process
Giuseppina Martella
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12685-12685
Open Access

Page 1 - Next Page

Scroll to top